300363 博腾股份
未开盘 10-08 09:30:00
资讯
新帖
简况
博腾股份（300363）披露2026年限制性股票激励计划首次授予第一类限制性股票登记完成公告，9月29日股价下跌1.34%
证券之星 · 09-29
博腾股份（300363）披露2026年限制性股票激励计划首次授予第一类限制性股票登记完成公告，9月29日股价下跌1.34%
博腾股份（300363）9月24日主力资金净卖出5102.99万元
证券之星 · 09-28
博腾股份（300363）9月24日主力资金净卖出5102.99万元
博腾股份：截至2026年9月10日股东总户数为43,578户
证券之星 · 09-24
博腾股份：截至2026年9月10日股东总户数为43,578户
研报掘金丨国海证券：维持博腾股份“买入”评级，后续盈利能力具备较大修复空间
格隆汇 · 09-24
研报掘金丨国海证券：维持博腾股份“买入”评级，后续盈利能力具备较大修复空间
博腾股份：9月23日召开业绩说明会，投资者参与
证券之星 · 09-24
博腾股份：9月23日召开业绩说明会，投资者参与
博腾股份（300363）披露关于拟更换公司独立董事及非独立董事的议案，9月23日股价上涨5.03%
证券之星 · 09-23
博腾股份（300363）披露关于拟更换公司独立董事及非独立董事的议案，9月23日股价上涨5.03%
博腾股份：公司目前服务项目和技术应用未涉及相关领域
证券之星 · 09-15
博腾股份：公司目前服务项目和技术应用未涉及相关领域
研报掘金丨浙商证券：维持博腾股份“买入”评级，主业盈利优化，看好提速趋势
格隆汇 · 09-09
研报掘金丨浙商证券：维持博腾股份“买入”评级，主业盈利优化，看好提速趋势
博腾股份（300363）股东居年丰质押630万股，占总股本1.16%
证券之星 · 09-04
博腾股份（300363）股东居年丰质押630万股，占总股本1.16%
博腾股份中报由盈转亏：海外项目爆雷，业务结构短板凸显
新浪证券 · 09-04
博腾股份中报由盈转亏：海外项目爆雷，业务结构短板凸显
博腾股份（300363）披露2026年限制性股票激励计划首次授予激励对象名单核查意见及公示情况说明，9月1日股价下跌0.88%
证券之星 · 09-01
博腾股份（300363）披露2026年限制性股票激励计划首次授予激励对象名单核查意见及公示情况说明，9月1日股价下跌0.88%
股市必读：博腾股份(300363)股东户数5.73万户，较上期增加19.28%
证券之星 · 08-28
股市必读：博腾股份(300363)股东户数5.73万户，较上期增加19.28%
博腾股份：截至2026年8月10日收盘，公司股东总户数（合并普通账户和融资融券信用账户）为57,295户
证券之星 · 08-27
博腾股份：截至2026年8月10日收盘，公司股东总户数（合并普通账户和融资融券信用账户）为57,295户
博腾股份：8月24日接受机构调研，东方证券、华福证券等多家机构参与
证券之星 · 08-25
博腾股份：8月24日接受机构调研，东方证券、华福证券等多家机构参与
博腾股份(300363)7月10日股东户数4.8万户，较上期减少0.2%
证券之星 · 08-22
博腾股份(300363)7月10日股东户数4.8万户，较上期减少0.2%
图解博腾股份中报：第二季度单季净利润同比下降904.20%
证券之星 · 08-22
图解博腾股份中报：第二季度单季净利润同比下降904.20%
博腾股份（300363）披露2026年半年度报告，8月21日股价下跌10.58%
证券之星 · 08-21
博腾股份（300363）披露2026年半年度报告，8月21日股价下跌10.58%
博腾股份(300363.SZ)发布上半年业绩，由盈转亏2.24亿元
智通财经 · 08-21
博腾股份(300363.SZ)发布上半年业绩，由盈转亏2.24亿元
8月7日博腾股份（300363）龙虎榜数据：机构净买入4759.01万元，北向资金净买入4894.9万元
证券之星 · 08-07
8月7日博腾股份（300363）龙虎榜数据：机构净买入4759.01万元，北向资金净买入4894.9万元
博腾股份最新公告：控股子公司取得药品生产许可证已具备承接细胞与基因治疗产品商业化受托生产的合规资质
证券之星 · 08-03
博腾股份最新公告：控股子公司取得药品生产许可证已具备承接细胞与基因治疗产品商业化受托生产的合规资质
加载更多
公司概况
公司名称：
重庆博腾制药科技股份有限公司
所属行业：
医药制造业
上市日期：
2014-01-29
主营业务：
重庆博腾制药科技股份有限公司的主营业务是为小分子药物、大分子药物及基因细胞治疗等不同类型的药物及疗法提供CDMO服务。公司的主要产品是小分子原料药业务、小分子制剂业务、细胞与基因治疗业务、新分子业务。报告期内，公司连续第三年获得某跨国制药公司颁发的“EHS外部合作伙伴卓越奖”荣誉。
发行价格：
25.10
{"stockData":{"symbol":"300363","market":"SZ","secType":"STK","nameCN":"博腾股份","latestPrice":24.56,"timestamp":1791421359000,"preClose":24.56,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":498000000,"shares":543000000,"eps":-0.2851,"marketStatus":"未开盘","change":0,"latestTime":"10-08 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.2851,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":0,"adr":0,"adjPreClose":24.56,"symbolType":"stock","openAndCloseTimeList":[[1791423000000,1791430200000],[1791435600000,1791442800000]],"highLimit":27.02,"lowLimit":22.1,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":543442176,"isCdr":false,"pbRate":2.69,"roa":"--","roe":"--","epsLYR":0.18,"committee":0,"marketValue":13347000000,"turnoverRate":0,"status":2,"floatMarketCap":12228000000},"requestUrl":"/m/hq/s/300363","defaultTab":"news","newsList":[{"id":"2671774210","title":"博腾股份（300363）披露2026年限制性股票激励计划首次授予第一类限制性股票登记完成公告，9月29日股价下跌1.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671774210","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671774210?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:09","pubTimestamp":1790690963,"startTime":"0","endTime":"0","summary":"近日，博腾股份披露《关于2026年限制性股票激励计划首次授予第一类限制性股票登记完成的公告》。公告显示，公司已完成2026年限制性股票激励计划首次授予的第一类限制性股票登记工作，登记完成日为2026年9月29日，授予数量为97.5万股，授予人数为7人，授予价格为10.99元/股，股票来源为公司从二级市场回购的A股普通股。本次授予的股份上市日期为2026年9月29日，公司总股本未发生变化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900039815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670407118","title":"博腾股份（300363）9月24日主力资金净卖出5102.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670407118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670407118?lang=zh_cn&edition=full","pubTime":"2026-09-28 09:20","pubTimestamp":1790558434,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，博腾股份报收于23.83元，下跌5.62%，换手率4.41%，成交量22.0万手，成交额5.36亿元。近5日资金流向一览见下表：博腾股份融资融券信息显示，融资方面，当日融资买入6135.89万元，融资偿还3852.49万元，融资净买入2283.39万元。博腾股份主营业务：小分子原料药业务,小分子制剂业务,基因细胞治疗业务,新分子业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800002838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669045044","title":"博腾股份：截至2026年9月10日股东总户数为43,578户","url":"https://stock-news.laohu8.com/highlight/detail?id=2669045044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669045044?lang=zh_cn&edition=full","pubTime":"2026-09-24 15:48","pubTimestamp":1790236098,"startTime":"0","endTime":"0","summary":"证券之星消息，博腾股份(300363)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至9月10日的最新股东数？谢谢。博腾股份回复：您好，截至2026年9月10日收盘，公司股东总户数（合并普通账户和融资融券信用账户）为43,578户。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400023443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669452425","title":"研报掘金丨国海证券：维持博腾股份“买入”评级，后续盈利能力具备较大修复空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2669452425","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669452425?lang=zh_cn&edition=full","pubTime":"2026-09-24 14:57","pubTimestamp":1790233031,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0174","000750","BK0028","BK0183","BK0188","BK0239","BK0276","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669776459","title":"博腾股份：9月23日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2669776459","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669776459?lang=zh_cn&edition=full","pubTime":"2026-09-24 13:01","pubTimestamp":1790226079,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月23日博腾股份发布公告称公司于2026年9月23日召开业绩说明会。博腾股份主营业务：小分子原料药业务,小分子制剂业务,基因细胞治疗业务,新分子业务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400019693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300363","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669481047","title":"博腾股份（300363）披露关于拟更换公司独立董事及非独立董事的议案，9月23日股价上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669481047","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669481047?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:11","pubTimestamp":1790172688,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，博腾股份报收于25.25元，较前一交易日上涨5.03%，最新总市值为137.22亿元。该股当日开盘24.03元，最高25.98元，最低23.96元，成交额达7.48亿元，换手率为5.9%。近日，博腾股份发布《关于召开2026年第二次临时股东会的通知》。会议将审议《关于拟更换公司独立董事的议案》和《关于拟更换公司非独立董事的议案》，上述议案需经出席会议股东所持表决权过半数通过。独立董事候选人需经深交所审核无异议后方可提交表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300040608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667613918","title":"博腾股份：公司目前服务项目和技术应用未涉及相关领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2667613918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667613918?lang=zh_cn&edition=full","pubTime":"2026-09-15 11:36","pubTimestamp":1789443397,"startTime":"0","endTime":"0","summary":"证券之星消息，博腾股份09月14日在投资者关系平台上答复投资者关心的问题。如果未来商业航天进一步降低在轨实验和样品返回成本，公司现有的晶型研究、结晶动力学和晶体结构解析平台，是否具备承接相关商业化项目的技术基础？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500015667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666588593","title":"研报掘金丨浙商证券：维持博腾股份“买入”评级，主业盈利优化，看好提速趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2666588593","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666588593?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:19","pubTimestamp":1788938362,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0276","601878","BK0239","BK0028","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664363933","title":"博腾股份（300363）股东居年丰质押630万股，占总股本1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664363933","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664363933?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:28","pubTimestamp":1788517708,"startTime":"0","endTime":"0","summary":"证券之星消息，博腾股份9月4日公开信息显示，股东居年丰向华能贵诚信托有限公司合计质押630.0万股，占总股本1.16%。质押详情见下表：截止本公告日，股东居年丰已累计质押股份3686.6万股，占其持股总数的62.6%，股东陶荣已累计质押股份1700.0万股，占其持股总数的38.45%，股东张和兵已累计质押股份1956.0万股，占其持股总数的46.68%。博腾股份主营业务：小分子原料药业务,小分子制剂业务,基因细胞治疗业务,新分子业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400035210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300363","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664826063","title":"博腾股份中报由盈转亏：海外项目爆雷，业务结构短板凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2664826063","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664826063?lang=zh_cn&edition=full","pubTime":"2026-09-04 15:25","pubTimestamp":1788506700,"startTime":"0","endTime":"0","summary":"2026 年半年报披露，博腾股份实现营业收入 17.90 亿元，同比增长 10.42%，但归母净利润亏损 2.24 亿元，同比由盈转亏。01海外项目暴雷，内外业务盈利严重分化本次半年报亏损的直接导火索，是斯洛文尼亚研发生产基地项目终止带来的资产减值。博腾股份被划入行业第二梯队，上半年 17.9 亿元营收，与第一梯队数百亿营收体量存在巨大鸿沟。而博腾股份业务结构集中，新业务尚未兑现收益，抗周期波动能力偏弱。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-04/doc-iniqryeu0877206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0239","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985784","title":"博腾股份（300363）披露2026年限制性股票激励计划首次授予激励对象名单核查意见及公示情况说明，9月1日股价下跌0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985784","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664985784?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:28","pubTimestamp":1788272897,"startTime":"0","endTime":"0","summary":"近日，博腾股份发布《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的核查意见及公示情况说明》。公告显示，公司于2026年8月20日召开第六届董事会第十二次会议，审议通过《2026年限制性股票激励计划（草案）》及其摘要；随后对首次授予激励对象的姓名和职务在内部办公系统进行公示，公示时间为2026年8月21日至8月31日，期间未收到任何异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662358082","title":"股市必读：博腾股份(300363)股东户数5.73万户，较上期增加19.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662358082","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662358082?lang=zh_cn&edition=full","pubTime":"2026-08-28 00:55","pubTimestamp":1787849713,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，博腾股份报收于20.2元，下跌1.85%，换手率5.2%，成交量25.93万手，成交额5.25亿元。当日关注点交易信息汇总：8月27日主力资金净流出5536.07万元，占总成交额10.54%。股本股东变化：截至2026年8月10日股东户数为5.73万户，较7月10日增加19.28%。股本股东变化股东户数变动截至2026年8月10日公司股东户数为5.73万户，较7月10日增加9259.0户，增幅为19.28%；户均持股数量由上期的1.13万股减少至9485.0股，户均持股市值为20.53万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800002602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662222127","title":"博腾股份：截至2026年8月10日收盘，公司股东总户数（合并普通账户和融资融券信用账户）为57,295户","url":"https://stock-news.laohu8.com/highlight/detail?id=2662222127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662222127?lang=zh_cn&edition=full","pubTime":"2026-08-27 11:36","pubTimestamp":1787801772,"startTime":"0","endTime":"0","summary":"证券之星消息，博腾股份(300363)08月26日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至8月10日公司股东人数是多少，谢谢博腾股份回复：截至2026年8月10日收盘，公司股东总户数（合并普通账户和融资融券信用账户）为57,295户。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700025873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662781207","title":"博腾股份：8月24日接受机构调研，东方证券、华福证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781207","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662781207?lang=zh_cn&edition=full","pubTime":"2026-08-25 09:36","pubTimestamp":1787621795,"startTime":"0","endTime":"0","summary":"今年上半年，CGT 新签订单约 9,188 万元，同比增长约 75%，其中来自海外客户的订单占比达 38%。1上半年，PI 产品收入下滑主要因两个商业化项目交付节奏原因，后续发货等相关安排将根据客户要求确认。博腾股份主营业务：小分子原料药业务,小分子制剂业务,基因细胞治疗业务,新分子业务。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500014707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600958","BK0028","BK0183","BK0188","BK1147","03958","BK0239","BK1564","BK0012","BK0276","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661921624","title":"博腾股份(300363)7月10日股东户数4.8万户，较上期减少0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661921624","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661921624?lang=zh_cn&edition=full","pubTime":"2026-08-22 17:09","pubTimestamp":1787389768,"startTime":"0","endTime":"0","summary":"证券之星消息，近日博腾股份披露，截至2026年7月10日公司股东户数为4.8万户，较6月30日减少98.0户，减幅为0.2%。在医疗服务行业个股中，博腾股份股东户数高于行业平均水平，截至7月10日，医疗服务行业平均股东户数为4.78万户。从股价来看，2026年6月30日至2026年7月10日，博腾股份区间涨幅为13.42%，在此期间股东户数减少98.0户，减幅为0.2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200015067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300363","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294023","title":"图解博腾股份中报：第二季度单季净利润同比下降904.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294023","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661294023?lang=zh_cn&edition=full","pubTime":"2026-08-22 01:56","pubTimestamp":1787335005,"startTime":"0","endTime":"0","summary":"证券之星消息，博腾股份2026年中报显示，上半年度公司主营收入17.9亿元，同比上升10.42%；归母净利润-2.24亿元，同比下降928.55%；扣非净利润-2.47亿元，同比下降3943.67%；其中2026年第二季度，公司单季度主营收入9.04亿元，同比上升10.25%；单季度归母净利润-2.52亿元，同比下降904.2%；单季度扣非净利润-2.72亿元，同比下降1744.54%；负债率35.4%，投资收益565.89万元，财务费用1775.29万元，毛利率32.23%。财报数据概要请见下图:本文数据来源于博腾股份2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200002074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296857","title":"博腾股份（300363）披露2026年半年度报告，8月21日股价下跌10.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296857","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661296857?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:04","pubTimestamp":1787321073,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，博腾股份报收于21.89元，较前一交易日下跌10.58%，最新总市值为118.96亿元。该股当日开盘23.33元，最高23.33元，最低21.38元，成交额达14.98亿元，换手率为13.75%。近日，博腾股份披露《2026年半年度报告》。经营活动产生的现金流量净额305,704,423.69元，同比增长22.19%。总资产7,854,647,700.93元，较上年度末减少8.14%；归属于上市公司股东的净资产4,956,981,575.93元，较上年度末减少7.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100044990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293638","title":"博腾股份(300363.SZ)发布上半年业绩，由盈转亏2.24亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293638","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661293638?lang=zh_cn&edition=full","pubTime":"2026-08-21 21:07","pubTimestamp":1787317649,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博腾股份(300363.SZ)发布2026年半年度报告，报告期内，公司实现营业收入17.9亿元，同比增长10.42%。归属于上市公司股东净亏损2.24亿元。归属于上市公司股东的扣除非经常性损益净亏损2.47亿元。主要由于公司终止斯洛文尼亚投资项目相关资产减值准备3.30亿元。2026年上半年，公司持续经营净利润9,232.77万元，同比增长约329%，盈利改善的主要原因公司营业收入规模化效应显现，带动公司整体毛利率提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614833","title":"8月7日博腾股份（300363）龙虎榜数据：机构净买入4759.01万元，北向资金净买入4894.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657614833?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:44","pubTimestamp":1786095870,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月7日公布的交易公开信息显示，博腾股份因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年8月7日收盘，博腾股份报收于20.44元，上涨20.02%，涨停，换手率14.77%，成交量73.17万手，成交额13.83亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入4759.01万元，北向资金合计净买入4894.9万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700030581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378284","title":"博腾股份最新公告：控股子公司取得药品生产许可证已具备承接细胞与基因治疗产品商业化受托生产的合规资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378284","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656378284?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:41","pubTimestamp":1785753664,"startTime":"0","endTime":"0","summary":"博腾股份(300363.SZ)公告称，公司二级控股子公司苏州博腾生物制药有限公司近日取得江苏省药品监督管理局核发的《药品生产许可证》，有效期至2031年7月26日。该许可证标志着苏州博腾已具备承接细胞与基因治疗产品商业化受托生产的合规资质，有利于促进公司细胞与基因治疗CDMO业务开展。本次取得《药品生产许可证》预计不会对公司2026年度业绩产生重大影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300029188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791421381520,"stockEarnings":[{"period":"1week","weight":-0.0273},{"period":"1month","weight":0.2745},{"period":"3month","weight":0.4966},{"period":"6month","weight":0.145},{"period":"1year","weight":-0.0429},{"period":"ytd","weight":0.0612}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆博腾制药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"43578人(较上一季度减少23.94%)","perCapita":"11425股","listingDate":"2014-01-29","address":"重庆市长寿区(长寿)化工园区精细化工一区","registeredCapital":"54344万元","survey":" 重庆博腾制药科技股份有限公司的主营业务是为小分子药物、大分子药物及基因细胞治疗等不同类型的药物及疗法提供CDMO服务。公司的主要产品是小分子原料药业务、小分子制剂业务、细胞与基因治疗业务、新分子业务。报告期内，公司连续第三年获得某跨国制药公司颁发的“EHS外部合作伙伴卓越奖”荣誉。","listedPrice":25.1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博腾股份(300363)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博腾股份(300363)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博腾股份,300363,博腾股份股票,博腾股份股票老虎,博腾股份股票老虎国际,博腾股份行情,博腾股份股票行情,博腾股份股价,博腾股份股市,博腾股份股票价格,博腾股份股票交易,博腾股份股票购买,博腾股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博腾股份(300363)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博腾股份(300363)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}